UBS AM’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.9M | Buy |
285,068
+27,406
| +11% | +$7.88M | 0.02% | 576 |
|
|
2025
Q1 | $79.4M | Buy |
257,662
+25,289
| +11% | +$7.8M | 0.02% | 589 |
|
|
2024
Q4 | $82M | Buy |
232,373
+19,716
| +9% | +$6.96M | 0.02% | 557 |
|
|
2024
Q3 | $76.2M | Sell |
212,657
-31,298
| -13% | -$11.2M | 0.02% | 581 |
|
|
2024
Q2 | $77.7M | Buy |
243,955
+79,333
| +48% | +$25.3M | 0.02% | 513 |
|
|
2024
Q1 | $37.8M | Buy |
164,622
+1,207
| +0.7% | +$277K | 0.01% | 651 |
|
|
2023
Q4 | $35.9M | Buy |
163,415
+9,999
| +7% | +$2.2M | 0.01% | 654 |
|
|
2023
Q3 | $34.7M | Buy |
153,416
+49,440
| +48% | +$11.2M | 0.02% | 651 |
|
|
2023
Q2 | $23.3M | Hold |
103,976
| – | – | 0.01% | 737 |
|
|
2023
Q1 | $23.3M | Buy |
103,976
+22,349
| +27% | +$5.01M | 0.01% | 737 |
|
|
2022
Q4 | $22.7M | Buy |
81,627
+1,679
| +2% | +$467K | 0.01% | 722 |
|
|
2022
Q3 | $16.7M | Sell |
79,948
-4,112
| -5% | -$861K | 0.01% | 808 |
|
|
2022
Q2 | $19.8M | Sell |
84,060
-6,055
| -7% | -$1.43M | 0.01% | 742 |
|
|
2022
Q1 | $16.2M | Buy |
90,115
+2,791
| +3% | +$501K | 0.01% | 906 |
|
|
2021
Q4 | $18.9M | Sell |
87,324
-7,923
| -8% | -$1.71M | 0.01% | 911 |
|
|
2021
Q3 | $17.6M | Buy |
95,247
+2,485
| +3% | +$459K | 0.01% | 903 |
|
|
2021
Q2 | $16.6M | Sell |
92,762
-21,968
| -19% | -$3.94M | 0.01% | 940 |
|
|
2021
Q1 | $19.2M | Sell |
114,730
-305
| -0.3% | -$51K | 0.01% | 874 |
|
|
2020
Q4 | $17.5M | Buy |
115,035
+7,116
| +7% | +$1.08M | 0.01% | 882 |
|
|
2020
Q3 | $10.9M | Sell |
107,919
-618
| -0.6% | -$62.4K | 0.01% | 922 |
|
|
2020
Q2 | $13.1M | Sell |
108,537
-5,072
| -4% | -$614K | 0.01% | 848 |
|
|
2020
Q1 | $10.8M | Buy |
113,609
+11,086
| +11% | +$1.05M | 0.01% | 843 |
|
|
2019
Q4 | $9.03M | Buy |
102,523
+46,100
| +82% | +$4.06M | 0.01% | 976 |
|
|
2019
Q3 | $4.5M | Sell |
56,423
-1,564
| -3% | -$125K | ﹤0.01% | 1247 |
|
|
2019
Q2 | $4.53M | Sell |
57,987
-223,761
| -79% | -$17.5M | ﹤0.01% | 1237 |
|
|
2019
Q1 | $33.1M | Buy |
281,748
+126,081
| +81% | +$14.8M | 0.02% | 609 |
|
|
2018
Q4 | $17M | Sell |
155,667
-1,009
| -0.6% | -$110K | 0.01% | 737 |
|
|
2018
Q3 | $20M | Buy |
156,676
+13,983
| +10% | +$1.79M | 0.01% | 754 |
|
|
2018
Q2 | $16.1M | Buy |
142,693
+13,092
| +10% | +$1.48M | 0.01% | 819 |
|
|
2018
Q1 | $14.6M | Buy |
129,601
+10,152
| +8% | +$1.14M | 0.01% | 830 |
|
|
2017
Q4 | $17.7M | Sell |
119,449
-5,288
| -4% | -$782K | 0.02% | 781 |
|
|
2017
Q3 | $14.6M | Buy |
124,737
+9,213
| +8% | +$1.08M | 0.01% | 816 |
|
|
2017
Q2 | $15M | Buy |
115,524
+9,606
| +9% | +$1.25M | 0.01% | 816 |
|
|
2017
Q1 | $14.3M | Sell |
105,918
-117,304
| -53% | -$15.9M | 0.01% | 811 |
|
|
2016
Q4 | $32M | Sell |
223,222
-34,242
| -13% | -$4.91M | 0.04% | 514 |
|
|
2016
Q3 | $30.4M | Buy |
257,464
+10,901
| +4% | +$1.29M | 0.03% | 527 |
|
|
2016
Q2 | $26.1M | Buy |
246,563
+20,278
| +9% | +$2.15M | 0.03% | 563 |
|
|
2016
Q1 | $25.2M | Buy |
226,285
+15,402
| +7% | +$1.72M | 0.03% | 565 |
|
|
2015
Q4 | $33M | Buy |
210,883
+107,084
| +103% | +$16.8M | 0.04% | 486 |
|
|
2015
Q3 | $13.6M | Buy |
103,799
+10,626
| +11% | +$1.39M | 0.02% | 792 |
|
|
2015
Q2 | $16.2M | Buy |
93,173
+57,901
| +164% | +$10.1M | 0.02% | 778 |
|
|
2015
Q1 | $6.08M | Buy |
35,272
+6,385
| +22% | +$1.1M | 0.01% | 1010 |
|
|
2014
Q4 | $3.74M | Sell |
28,887
-24,147
| -46% | -$3.13M | ﹤0.01% | 1115 |
|
|
2014
Q3 | $6.82M | Buy |
53,034
+3,840
| +8% | +$494K | 0.01% | 965 |
|
|
2014
Q2 | $4.35M | Sell |
49,194
-17,694
| -26% | -$1.57M | ﹤0.01% | 1064 |
|
|
2014
Q1 | $6.29M | Buy |
66,888
+29,070
| +77% | +$2.73M | 0.01% | 987 |
|
|
2013
Q4 | $4.28M | Buy |
37,818
+1,650
| +5% | +$187K | ﹤0.01% | 1039 |
|
|
2013
Q3 | $2.85M | Sell |
36,168
-1,559
| -4% | -$123K | ﹤0.01% | 1129 |
|
|
2013
Q2 | $2.48M | Buy |
+37,727
| New | +$2.48M | ﹤0.01% | 1139 |
|